Sort   by:  
 Page size 
UnknownEvaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.
Not available
S-EPMC11632942 | biostudies-literature
UnknownPartnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Not available
S-EPMC7823170 | biostudies-literature
UnknownImmunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Not available
S-EPMC11006114 | biostudies-literature
UnknownLong-term cellular immunity of vaccines for Zaire Ebola Virus Diseases.
Not available
S-EPMC11372064 | biostudies-literature
Sort   by:  
 Page size